<b>Gapping up <br/>In reaction to strong earnings/guidance:</b><br/><br/>ACHN +20.2%, OTIV +20.2%, OREX +18%, NOG +15%, ENG +13.8%, SSTI +13.5%, VCEL +13.3%, NVAX +11.2%, TROX +11.2%, TPIC +10.8%, ACAD +10.4%, HTGM +8.7%, PXLW +8.7%, EVRI +8.5%, GSVC +8.5%, NVTR +8.1%, RRGB +7.9%, GPOR +7.8%, REXX +7.7%, ALDR +7.6%, ALRM +7.6%, YUME +7.1%, NVO +6.7%, SN +6.3%, SSNI +6.2%, ATHM +6.2%, WWW +6.2%, WATT +5.5%, ARLZ +5.3%, KAR +4.8%, OMER +4.7%, NSTG +4.6%, (NanoString Technologies and Lam Research (LRCX) announce strategic collaboration to develop NanoString's proprietary Hyb & Seq next generation sequencing platform), TPVG +4.3%, SSYS +4.3%, HTZ +3.6%, CLDX +3.5%, JNCE +3.4%, PRSC +3.3%, ARRY +3.2%, GNCA +2.9%, ECYT +2.8%, PUMP +2.6%, ARDX +2.6%, HALO +2.5%, IOSP +2.5%, ABCO +2.4%, NKTR +2.3%, DRRX +2.3%, DXC +2.3%, CARS +2.3%, ENPH +2.2%, RELY +2%, DHT +2%, TGTX +2%, PRMW +1.9%, ARA +1.9%, ETP +1.9%, PTCT +1.9%, MGIC +1.9%, AIMT +1.8%, AVT +1.8%, XEC +1.6%, PLPM +1.6%, WEN +1.6%, PLX +1.5%, ERI +1.3%, BUFF +1.3%, (approves $50 mln share repurchase program), CEMP +1.3%, BCEI +1.2%, IPXL +1%, MDCO +1%, .<br/><b>M&A news:</b><br/>STS +35.4% ( Wabash National Corporation (WNC) to acquire Supreme Industries in cash tender offer for $21 per share -- represents equity value of $364 mln and enterprise value of $342 mln; to be accretive in first full calendar year after close)<br/>TEVA +1.7% (reports the company may look to accelerate potential asset sales)<br/>PLPM +1.6% (to explore and evaluate potential strategic alternatives)<br/>CFMS +1.1% (acquires the machining and polishing assets of Broad Peak Manufacturing for approximately $6.5 million)<b><br/>Other news:<br/></b>XTNT +28.4% (FDA has cleared product line extensions for the Calix-C family of cervical interbody cages)<br/>RXII +12.1% (enters into common stock purchase agreement with Lincoln Park Capital)<br/>MBRX +8.7% (comments on 'several recent FDA approvals for new drugs for the treatment of acute myeloid leukemia')<br/>ANTH +6.8% (granted orphan drug designation by the FDA for blisibimod for the treatment of patients with immunoglobulin A nephropathy)<br/>YNDX +3.9% (Yandex N.V. and Sberbank (SBRCY) form JV; Sberbank to invest $500 mln into Yandex.Market)<br/><b>Analyst comments:</b><br/>RIG +1.2% (upgraded to Neutral from Sell at Goldman)<br/>VOD +0.6% (upgraded to Buy from Neutral at BofA/Merrill)<br/><br/><b>Gapping down<br/>In reaction to disappointing earnings/guidance:</b><br/>FOSL -24.1%, TARO -13.2%, TRUE -12.6%, VSI -12.5%, MXL -12.3%, XCO -12.3%, WAIR -11.1%, ARTX -9.9%, SGRY -9.9%, MYL -9.6%, POLA -9.1%, KNDI -8.8%, JAZZ -8.1%, ODP -7.5%, NUAN -7.4%, TRIP -7.3%, CALX -7.3%, TWNK -7.3%, PCLN -7%, POWL -6.9%, PLCE -6.8%, OCUL -6.7%, DIS -5.1%, (also acquires majority of BAMTech for $1.58 bln), BLCM -4.8%, TDW -4.2%, VSAT -4.1%, LITE -3.7%, CALA -3.4%, MNST -3.3%, BBSI -3.2%, CROX -3.1%, TAST -3%, WB -2.4%, MHLD -1.9%, RAS -1.8%, AVEO -1.8%, AFSI -1.6%, EGRX -1.6%, SINA -1.6%, LSCC -1.3%, YPF -1.3%, AXAS -1.2%, FLXN -1.1%, TLGT -1%, MRCC -1%, MYGN -1%, PGNX -1%, CYBR -0.9%, AAL -0.9%<br/><b>Other news:</b><br/>LOB -7.9% ( to offer approximately 4.5 mln shares of its voting common stock)<br/>MBUU -6.1% (to offer 2 mln shares of the Company's Class A Common Stock; discloses prelim results, sees Q4 revs $74.7-75.1 mln vs $70.34 mln Capital IQ Consensus Estimate, believes unit volume will be approximately 1,004 units, sees gross profit of $19.6-20 mln)<br/>HR -5.9% (prices 7.25 mln shares of common stock at $30.90 per share)<br/>PRAH -5.1% (PRA Health Sciences announces secondary offering of 10,000,000 shares of common stock by stockholders, including an affiliate of, or a fund sponsored by, Kohlberg Kravis Roberts & Co)<br/>ESPR -4.2% (to offer $150 million of its common stock)<br/>NFLX -3.7% (Disney will end distribution agreement with Netflix in 2019)<br/>H -2.4% (commences secondary offering 8,654,050 shares of Class A common stock )<br/>TMO -1.2% (prices offering of 8,771,930 shares of common stock at a price of $171.00 per share)<br/>MKC -0.8% (McCormick prices offering of 5,524,862 shares of its common stock at $90.50 per share)<br/><b>Analyst comments:</b><br/>AIG -0.9% (downgraded to Neutral from Overweight at Atlantic Equities)<br/>SBUX -0.7% (downgraded to Market Perform from Outperform at BMO Capital Markets)<br/><br/>Briefing.com